Hemagglutinin complex protein and application thereof

    公开(公告)号:US12173034B2

    公开(公告)日:2024-12-24

    申请号:US16766596

    申请日:2018-11-22

    Abstract: The present invention provides a miniaturized hemagglutinin complex protein having function inhibitory activity against E-cadherin, wherein (a) all or a part of at least HA1 subcomponent, and/or a part of HA3 subcomponent are/is deleted, (b) regions in HA2 and HA3 subcomponents that contribute to binding with E-cadherin are present, and (c) the HA3 subcomponent is derived from Clostridium botulinum type A or type B, and an E-cadherin function inhibitor containing the hemagglutinin complex protein.

Patent Agency Ranking